Antibody_NN Responses_NNS of_IN Cattle_NNS with_IN Respiratory_NP Coronavirus_NP Infections_NNS during_IN Pathogenesis_NP of_IN Shipping_NP Fever_NP Pneumonia_NP Are_NP Lower_NP with_IN Antigens_NNS of_IN Enteric_NP Strains_NP than_IN with_IN Those_NP of_IN a_DT Respiratory_NP Strain_NP The_DT serum_NN antibody_NN responses_NNS of_IN cattle_NNS with_IN respiratory_JJ coronavirus_NN infections_NNS during_IN the_DT pathogenesis_NN of_IN shipping_VBG fever_NN pneumonia_NN were_VBD analyzed_VBN with_IN different_JJ bovine_JJ coronavirus_NN antigens_NNS ,_, including_VBG those_DT from_IN a_DT wild-type_JJ respiratory_JJ bovine_JJ coronavirus_NN (_( RBCV_NP )_) strain_NN (_( 97TXSF-Lu_NP 15-2_CD )_) directly_RB isolated_VBN from_IN lung_NN tissue_NN from_IN a_DT fatally_RB infected_JJ bovine_NN ,_, a_DT wild-type_NN enteropathogenic_JJ bovine_JJ coronavirus_NN (_( EBCV_NP )_) strain_NN (_( Ly_NP 138-3_CD )_) ,_, and_CC the_DT highly_JJ cell_NN culture-adapted_JJ ,_, enteric_JJ prototype_NN strain_NN (_( EBCV_NP L9-81_NP )_) ._SENT Infectivity-neutralizing_NP (_( IN_IN )_) and_CC hemagglutinin-inhibiting_JJ (_( HAI_NP )_) activities_NNS were_VBD tested_VBN ._SENT Sequential_JJ serum_NN samples_NNS ,_, collected_VBN during_IN the_DT onset_NN of_IN the_DT respiratory_JJ coronavirus_NN infection_NN and_CC at_IN weekly_JJ intervals_NNS for_IN 5_CD weeks_NNS thereafter_RB ,_, had_VBD significantly_RB higher_JJR IN_IN and_CC HAI_NP titers_NNS for_IN antigens_NNS of_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN than_IN for_IN the_DT wild-type_NN and_CC the_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP strains_NNS ,_, with_IN P_NN values_NNS ranging_VBG from_IN <0.0001_NN to_TO 0.0483_CD ._SENT The_DT IN_IN and_CC HAI_NP antibody_NN responses_NNS against_IN the_DT two_CD EBCV_NP strains_NNS did_VBD not_RB differ_VB significantly_RB ,_, but_CC the_DT lowest_JJS titers_NNS were_VBD detected_VBN with_IN EBCV_NP strain_NN L9-81_NP ._SENT The_DT role_NN of_IN coronaviruses_NNS as_IN respiratory_JJ pathogens_NNS in_IN cattle_NNS was_VBD recently_RB recognized_VBN when_WRB numerous_JJ coronavirus_NN strains_NNS were_VBD isolated_VBN from_IN the_DT nasal_JJ secretions_NNS and_CC lung_NN tissues_NNS from_IN cattle_NNS with_IN fatal_JJ cases_NNS of_IN shipping_VBG fever_NN pneumonia_NN (_( SFP_NP )_) ._SENT These_DT isolates_NNS are_VBP referred_VBN to_TO as_RB respiratory_JJ bovine_JJ coronaviruses_NNS (_( RBCV_NP )_) ._SENT The_DT enteropathogenic_JJ potential_NN of_IN coronaviruses_NNS was_VBD identified_VBN previously_RB when_WRB these_DT viruses_NNS were_VBD isolated_VBN from_IN diarrhea_NN fluid_NN or_CC intestinal_JJ samples_NNS from_IN neonatal_JJ calves_NNS with_IN severe_JJ diarrhea_NN ._SENT In_IN addition_NN ,_, coronaviruses_NNS were_VBD implicated_VBN in_IN winter_NN dysentery_NN of_IN adult_JJ cattle_NNS ._SENT These_DT coronaviruses_NNS are_VBP referred_VBN to_TO as_RB enteropathogenic_JJ bovine_JJ coronaviruses_NNS (_( EBCV_NP )_) ._SENT Significant_JJ phenotypic_JJ ,_, antigenic_JJ ,_, and_CC genetic_JJ differences_NNS separate_VBP the_DT newly_RB recognized_VBN RBCV_NP from_IN EBCV_NP ._SENT Furthermore_RB ,_, infectivity-neutralizing_VBG (_( IN_IN )_) monoclonal_NN antibodies_NNS (_( MAb_NP )_) distinguished_VBD between_IN the_DT EBCV_NP wild-type_NN strain_NN LY138-3_NP and_CC the_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP strain_NN L9-81_NP ,_, as_RB well_RB as_IN the_DT Norden_NP vaccine_NN strain_NN ._SENT Bovine_JJ coronaviruses_NNS are_VBP enveloped_VBN ,_, have_VBP a_DT positive_JJ single-stranded_JJ RNA_NP genome_NN of_IN about_RB 31_CD kb_NN ,_, and_CC belong_VBP to_TO the_DT Coronaviridae_NP family_NN of_IN the_DT order_NN Nidovirales_NP ._SENT The_DT spike_NN (_( S_NP )_) and_CC the_DT hemagglutinin_NN esterase_NN (_( HE_JJ )_) glycoproteins_NNS of_IN the_DT five_CD structural_JJ proteins_NNS function_VBP in_IN the_DT infectious_JJ process_NN through_IN adsorption_NN and_CC coadsorption_NN to_TO the_DT receptors_NNS on_IN susceptible_JJ host_NN cells_NNS ._SENT The_DT S_NP and_CC HE_NP glycoproteins_NNS are_VBP both_DT capable_JJ of_IN hemagglutinating_VBG rodent_NN and_CC chicken_NN red_JJ blood_NN cells_NNS (_( RBC_NP )_) ._SENT The_DT HE_NN but_CC not_RB S_NP glycoprotein_NN facilitates_VBZ the_DT release_NN of_IN viruses_NNS adsorbed_VBN to_TO RBC_NP in_IN the_DT receptor-destroying_NN enzyme_NN (_( RDE_NP )_) test_NN mediated_VBN by_IN an_DT acetylesterase_NN (_( AE_NP )_) component_NN of_IN the_DT HE_JJ (_( -_: ,_, ,_, )_) ._SENT These_DT two_CD glycoproteins_NNS induce_VB IN_IN and_CC hemagglutinin-inhibiting_NN (_( HAI_NP )_) antibodies_NNS ._SENT The_DT objectives_NNS of_IN the_DT present_JJ investigations_NNS were_VBD to_TO assess_VB the_DT antibody_NN responses_NNS of_IN cattle_NNS during_IN a_DT naturally_RB occurring_VBG and_CC experimentally_RB monitored_VBN infection_NN that_WDT had_VBD induced_VBN severe_JJ pneumonic_JJ signs_NNS ,_, including_VBG SFP_NP ._SENT The_DT kinetics_NNS of_IN IN_IN and_CC HAI_NP antibody_NN responses_NNS of_IN these_DT cattle_NNS were_VBD analyzed_VBN with_IN antigens_NNS of_IN an_DT endogenous_JJ RBCV_NP strain_NN ,_, which_WDT were_VBD isolated_VBN from_IN lung_NN tissue_NN from_IN a_DT fatally_RB infected_VBN bovine_JJ from_IN this_DT SFP_NP epizootic_JJ ,_, and_CC with_IN antigens_NNS of_IN the_DT wild-type_NN and_CC the_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP strains_NNS ._SENT The_DT analysis_NN was_VBD conducted_VBN with_IN sera_NN sequentially_RB collected_VBN from_IN cattle_NNS which_WDT had_VBD primary_JJ and_CC secondary_JJ immune_JJ responses_NNS to_TO the_DT RBCV_NP infection_NN ._SENT Experimental_JJ design_NN ._SENT |_SYM One_CD hundred_CD five_CD 6-_CD to_TO 8-month-old_JJ cattle_NNS were_VBD involved_VBN in_IN this_DT specific_JJ epizootic_JJ and_CC were_VBD subjected_VBN to_TO nasal_JJ swab_NN and_CC blood_NN sampling_NN and_CC testing_NN at_IN the_DT time_NN of_IN assembly_NN at_IN the_DT order-buyer_NN 's_POS barn_NN (_( day_NN 0_CD )_) ,_, after_IN transport_NN on_IN day_NN 7_CD ,_, and_CC thereafter_RB on_IN days_NNS 14_CD ,_, 21_CD ,_, 28_CD ,_, and_CC 35_CD ,_, during_IN the_DT pathogenesis_NN of_IN and_CC recovery_NN from_IN SFP_NP ._SENT Nasal_JJ swab_NN samples_NNS were_VBD taken_VBN for_IN virological_JJ and_CC bacteriological_JJ studies_NNS ,_, while_IN blood_NN samples_NNS for_IN serum_NN harvest_NN were_VBD collected_VBN for_IN immunological_JJ investigations_NNS ._SENT The_DT cattle_NNS were_VBD separated_VBN into_IN five_CD response_NN groups_NNS based_VBN on_IN clinical_JJ signs_NNS of_IN respiratory_JJ tract_NN diseases_NNS and_CC results_NNS of_IN RBCV_NP isolations_NNS ._SENT Response_NN groups_NNS 1_CD and_CC 5_CD were_VBD utilized_VBN in_IN the_DT present_JJ analysis_NN ._SENT Response_NN group_NN 1_CD included_VBD 72_CD cattle_NNS that_WDT exhibited_VBD clinical_JJ signs_NNS of_IN respiratory_JJ tract_NN disease_NN and_CC that_IN nasally_RB shed_VBN RBCV_NP on_IN day_NN 0_CD ,_, day_NN 7_CD ,_, or_CC both_DT ._SENT Seven_CD randomly_RB selected_VBN cattle_NNS of_IN the_DT group_NN shedding_VBG RBCV_NP on_IN day_NN 7_CD were_VBD investigated_VBN in_IN detail_NN ._SENT Seven_CD calves_NNS in_IN response_NN group_NN 5_CD were_VBD also_RB included_VBN in_IN these_DT serological_JJ investigations_NNS because_IN they_PP remained_VBD clinically_RB healthy_JJ and_CC RBCV_NP isolation_NN negative_JJ during_IN the_DT epizootic_JJ and_CC the_DT 5-week_JJ follow-up_NN period_NN ._SENT To_TO analyze_VB sequential_JJ serum_NN samples_NNS from_IN the_DT 14_CD cattle_NNS selected_VBN for_IN their_PP$ IN_IN and_CC HAI_NP antibodies_NNS ,_, we_PP used_VBD antigens_NNS of_IN three_CD specific_JJ strains_NNS of_IN bovine_JJ coronaviruses_NNS ._SENT Cell_NN line_NN ,_, virus_NN isolates_NNS ,_, and_CC virus_NN purification_NN ._SENT |_SYM Clone_NP G_NP of_IN human_JJ rectal_JJ tumor_NN (_( HRT-18_NP )_) cells_NNS was_VBD used_VBN at_IN the_DT 24th_JJ passage_NN level_NN for_IN RBCV_NP and_CC EBCV_NP propagation_NN ._SENT The_DT wild-type_JJ RBCV_NP strain_NN 97TXSF-Lu15-2_NN was_VBD used_VBN at_IN its_PP$ second_JJ passage_NN in_IN clone_NN G_NN cells_NNS after_IN initial_JJ isolation_NN from_IN lung_NN tissue_NN from_IN a_DT calf_NN that_WDT died_VBD on_IN day_NN 8_CD of_IN the_DT epizootic_JJ ._SENT The_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP strain_NN L9-81_NP was_VBD originally_RB isolated_VBN from_IN bovine_JJ fetal_JJ kidney_NN cell_NN cultures_NNS as_IN the_DT EBCV_NP Mebus_NP strain_NN ._SENT The_DT EBCV_NP L9-81_NP strain_NN was_VBD propagated_VBN in_IN 75_CD sequential_JJ passages_NNS in_IN different_JJ bovine_JJ cell_NN cultures_NNS ,_, and_CC the_DT final_JJ six_CD passages_NNS were_VBD done_VBN in_IN clone_NN G_NN cells_NNS ._SENT The_DT virulent_JJ wild-type_NN EBCV_NP strain_NN LY138-3_NP from_IN intestinal_JJ samples_NNS of_IN a_DT diarrheic_JJ calf_NN was_VBD initially_RB maintained_VBN by_IN oral_JJ inoculation_NN of_IN conventional_JJ calves_NNS with_IN induction_NN of_IN enteritis_NN ._SENT It_PP was_VBD used_VBN as_IN an_DT antigen_NN in_IN its_PP$ third_JJ clone_NN G_NN passage_NN ._SENT Partially_RB purified_VBN preparations_NNS of_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strains_NNS L9-81_NP and_CC LY138-3_NP were_VBD employed_VBN for_IN serological_JJ tests_NNS ._SENT IN_IN assay_NN ._SENT |_SYM Serum_NP samples_NNS were_VBD prepared_VBN in_IN quadruplicate_NN and_CC tested_VBN for_IN IN_IN activities_NNS according_VBG to_TO a_DT previously_RB reported_VBN method_NN ._SENT Serum_NP 1745_CD with_IN an_DT IN_IN titer_NN of_IN 128_CD and_CC BCV_NP antibody-free_JJ serum_NN from_IN a_DT normal_JJ calf_NN with_IN an_DT IN_IN titer_NN of_IN <8_NN were_VBD included_VBN as_IN positive_JJ and_CC negative_JJ controls_NNS ,_, respectively_RB ._SENT The_DT serum_NN IN_IN titers_NNS were_VBD expressed_VBN as_IN the_DT reciprocal_NN of_IN the_DT highest_JJS serum_NN dilution_NN that_WDT completely_RB inhibited_VBD cytopathic_JJ changes_NNS in_IN 50_CD %_NN of_IN the_DT wells_NNS ._SENT Assays_NNS for_IN HA_NP and_CC RDE_NP ._SENT |_SYM The_DT assays_NNS for_IN hemagglutinin_NN (_( HA_NP )_) and_CC RDE_NP were_VBD performed_VBN as_IN reported_VBN previously_RB with_IN washed_JJ rat_NN RBC_NP prepared_VBN as_IN 0.5_CD %_NN suspensions_NNS with_IN phosphate-buffered_JJ saline_NN (_( pH_NN 7.4_CD )_) containing_VBG 0.05_CD %_NN bovine_JJ serum_NN albumin_NN ._SENT HAI_NNS test_VBP ._SENT |_SYM The_DT HAI_NP titers_NNS of_IN serum_NN samples_NNS were_VBD determined_VBN with_IN partially_RB purified_VBN virus_NN stocks_NNS ,_, which_WDT were_VBD diluted_VBN to_TO contain_VB 8_CD to_TO 16_CD U_NN of_IN both_DT HA_NP and_CC RDE_NP as_IN antigens_NNS ._SENT Again_RB ,_, serum_NN 1745_CD with_IN an_DT HAI_NP titer_NN of_IN 128_CD was_VBD included_VBN as_IN a_DT positive_JJ control_NN ,_, while_IN BCV_NP antibody-free_JJ serum_NN from_IN a_DT normal_JJ calf_NN with_IN an_DT HAI_NP titer_NN of_IN <8_NN was_VBD used_VBN as_IN a_DT negative_JJ control_NN ._SENT The_DT serum_NN HAI_NP titers_NNS were_VBD expressed_VBN as_IN the_DT reciprocal_NN of_IN the_DT highest_JJS dilution_NN of_IN serum_NN sample_NN that_WDT completely_RB inhibited_VBD the_DT aggregation_NN of_IN rat_NN RBC_NP ._SENT Data_NP analysis_NN and_CC statistical_JJ methods_NNS ._SENT |_SYM The_DT serum_NN IN_IN and_CC HAI_NP titers_NNS were_VBD transformed_VBN to_TO base_VB 2_CD logarithms_NNS for_IN statistical_JJ analysis_NN ._SENT All_DT data_NNS were_VBD presented_VBN as_IN means_NN +-_NN standard_JJ errors_NNS of_IN the_DT means_NNS ._SENT The_DT IN_IN and_CC HAI_NP activities_NNS of_IN the_DT two_CD response_NN groups_NNS were_VBD compared_VBN by_IN an_DT analysis_NN of_IN variance_NN of_IN repeated_JJ measures_NNS designed_VBN with_IN a_DT split-plot_NN arrangement_NN of_IN treatments_NNS ._SENT Pairwise_JJ comparisons_NNS of_IN treatment_NN and_CC day_NN differences_NNS were_VBD assessed_VBN with_IN Scheffe_NP 's_POS test_NN ._SENT Interaction_NN effects_NNS were_VBD examined_VBN with_IN pairwise_JJ t_NN tests_NNS of_IN least-squares_NNS means_VBZ for_IN preplanned_JJ comparisons_NNS of_IN treatments_NNS at_IN specific_JJ day_NN levels_NNS ._SENT All_DT tests_NNS were_VBD considered_VBN significant_JJ at_IN a_DT probability_NN of_IN <0.05_NN ._SENT Comparison_NN of_IN IN_IN activities_NNS of_IN serial_JJ serum_NN samples_NNS with_IN antigens_NNS of_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strains_NNS L9-81_NP and_CC LY138-3_NP ._SENT |_SYM The_DT antibody_NN responses_NNS with_IN serum_NN samples_NNS collected_VBN from_IN cattle_NNS in_IN response_NN groups_NNS 1_CD and_CC 5_CD had_VBD significantly_RB higher_JJR overall_JJ kinetics_NNS of_IN IN_IN activities_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN than_IN against_IN EBCV_NP strain_NN L9-81_NP ,_, with_IN P_NN values_NNS of_IN 0.0001_CD and_CC 0.0001_CD ,_, and_CC EBCV_NP strain_NN LY138-3_NP ,_, with_IN P_NN values_NNS of_IN 0.0001_CD and_CC 0.0025_CD ,_, respectively_RB ._SENT Significant_JJ differences_NNS in_IN IN_IN activities_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strain_NN L9-81_NP were_VBD observed_VBN in_IN serum_NN samples_NNS collected_VBN from_IN cattle_NNS in_IN response_NN group_NN 1_CD ,_, with_IN P_NN values_NNS of_IN 0.0439_CD ,_, 0.001_CD ,_, <0.0001_JJ ,_, <0.0001_JJ ,_, and_CC <0.0001_JJ for_IN results_NNS on_IN days_NNS 7_CD ,_, 14_CD ,_, 21_CD ,_, 28_CD ,_, and_CC 35_CD ,_, respectively_RB ._SENT Similarly_RB ,_, the_DT cattle_NNS in_IN response_NN group_NN 5_CD had_VBD significantly_RB lower_JJR levels_NNS on_IN days_NNS 7_CD ,_, 14_CD ,_, and_CC 28_CD ,_, with_IN P_NN values_NNS of_IN 0.0095_CD ,_, 0.0164_CD ,_, and_CC 0.0164_CD ,_, respectively_RB ._SENT Significant_JJ differences_NNS between_IN serum_NN IN_IN activities_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC these_DT against_IN the_DT EBCV_NP strain_NN LY138-3_NP antigen_NN were_VBD also_RB detected_VBN for_IN cattle_NNS in_IN response_NN group_NN 1_CD ,_, with_IN P_NN values_NNS of_IN 0.0029_CD ,_, <0.0001_JJ ,_, 0.001_CD ,_, and_CC <0.0001_JJ for_IN results_NNS for_IN days_NNS 14_CD ,_, 21_CD ,_, 28_CD ,_, and_CC 35_CD ,_, respectively_RB ,_, and_CC for_IN cattle_NNS of_IN response_NN group_NN 5_CD on_IN days_NNS 7_CD ,_, 14_CD ,_, and_CC 28_CD (_( P_NN values_NNS of_IN 0.0446_CD ,_, 0.0399_CD ,_, and_CC 0.0335_CD ,_, respectively_RB )_) ._SENT Interestingly_RB ,_, IN_IN antibody_NN titers_NNS against_IN EBCV_NP strains_NNS L9-81_NP and_CC LY138-3_NP in_IN cattle_NNS of_IN response_NN groups_NNS 1_CD and_CC 5_CD did_VBD not_RB differ_VB significantly_RB during_IN this_DT 5-week_JJ investigation_NN ._SENT Comparison_NN of_IN HAI_NP activities_NNS of_IN serial_JJ serum_NN samples_NNS with_IN antigens_NNS of_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strains_NNS L9-81_NP and_CC LY138-3_NP ._SENT |_SYM The_DT kinetics_NN of_IN the_DT responses_NNS in_IN HAI_NP antibodies_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN were_VBD significantly_RB greater_JJR than_IN those_DT against_IN EBCV_NP strain_NN L9-81_NP ,_, with_IN P_NN values_NNS of_IN 0.0001_CD and_CC 0.0001_CD for_IN the_DT results_NNS for_IN cattle_NNS of_IN response_NN groups_NNS 1_CD and_CC 5_CD ,_, respectively_RB ._SENT The_DT differences_NNS between_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strain_NN LY138_NP were_VBD significant_JJ at_IN a_DT P_NN value_NN of_IN 0.0001_CD for_IN both_DT groups_NNS 1_CD and_CC 5_CD ._SENT The_DT HAI_NP activities_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strain_NN L9-81_NP were_VBD remarkably_RB different_JJ in_IN serum_NN samples_NNS collected_VBN from_IN cattle_NNS in_IN response_NN group_NN 1_CD for_IN days_NNS 7_CD ,_, 14_CD ,_, 21_CD ,_, 28_CD ,_, and_CC 35_CD ,_, respectively_RB ,_, with_IN P_NN values_NNS of_IN 0.0483_CD ,_, 0.0004_CD ,_, 0.0035_CD ,_, <0.0001_JJ ,_, <0.0001_JJ ,_, and_CC <0.0001_JJ ._SENT The_DT HAI_NP activities_NNS showed_VBD similar_JJ differences_NNS among_IN cattle_NNS in_IN response_NN group_NN 5_CD from_IN day_NN 0_CD onward_RB with_IN a_DT P_NN value_NN of_IN <0.0001_NN ._SENT Levels_NNS of_IN HAI_NP antibodies_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN and_CC EBCV_NP strain_NN LY138-3_NP were_VBD also_RB substantially_RB different_JJ for_IN the_DT cattle_NNS in_IN response_NN group_NN 1_CD for_IN days_NNS 7_CD ,_, 14_CD ,_, 21_CD ,_, 28_CD ,_, and_CC 35_CD (_( P_NN values_NNS of_IN 0.0035_CD ,_, 0.0483_CD ,_, <0.0001_JJ ,_, 0.0001_CD ,_, and_CC <0.0001_JJ ,_, respectively_RB )_) ,_, and_CC for_IN the_DT cattle_NNS in_IN response_NN group_NN 5_CD for_IN days_NNS 0_CD ,_, 7_CD ,_, 14_CD ,_, 21_CD ,_, 28_CD ,_, and_CC 35_CD (_( P_NN values_NNS of_IN 0.0024_CD ,_, <0.0001_JJ ,_, <0.0001_JJ ,_, <0.0001_JJ ,_, <0.0001_JJ ,_, and_CC <0.0001_JJ ,_, respectively_RB )_) ._SENT Significant_JJ differences_NNS between_IN serum_NN HAI_NP antibody_NN kinetics_NNS against_IN EBCV_NP strain_NN L9-81_NP and_CC EBCV_NP strain_NN LY138-3_NP were_VBD not_RB observed_VBN in_IN cattle_NNS of_IN either_DT response_NN group_NN ._SENT FIG._NN 1_CD ._SENT |_SYM IN_IN (_( A_NP and_CC B_NP )_) and_CC HAI_NP (_( C_NP and_CC D_NP )_) antibody_NN responses_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN (_( circles_NNS )_) ,_, EBCV_NP strain_NN L9-81_NP (_( triangles_NNS )_) ,_, and_CC EBCV_NP strain_NN LY138-3_NP (_( squares_NNS )_) in_IN serum_NN samples_NNS from_IN cattle_NNS ._SENT IN_IN (_( A_NP and_CC B_NP )_) and_CC HAI_NP (_( C_NP and_CC D_NP )_) antibody_NN responses_NNS against_IN RBCV_NP strain_NN 97TXSF-Lu15-2_NN (_( circles_NNS )_) ,_, EBCV_NP strain_NN L9-81_NP (_( triangles_NNS )_) ,_, and_CC EBCV_NP strain_NN LY138-3_NP (_( squares_NNS )_) in_IN serum_NN samples_NNS from_IN cattle_NNS ._SENT Cattle_NNS in_IN response_NN group_NN 1_CD (_( A_NP and_CC C_NP )_) shed_VBD RBCV_NP on_IN day_NN 7_CD and_CC had_VBD clinical_JJ signs_NNS of_IN respiratory_JJ tract_NN disease_NN ,_, while_IN cattle_NNS in_IN response_NN group_NN 5_CD (_( B_NP and_CC D_NP )_) did_VBD not_RB develop_VB adverse_JJ clinical_JJ signs_NNS and_CC remained_VBD virus_NN isolation_NN negative_JJ ,_, despite_IN exposure_NN to_TO the_DT animals_NNS that_WDT were_VBD shedding_VBG virus_NN (_( response_NN group_NN 1_CD )_) ._SENT Data_NNS are_VBP means_VBZ +-_JJ standard_JJ errors_NNS of_IN the_DT means_NNS (_( error_NN bars_NNS )_) ._SENT Results_NNS are_VBP shown_VBN for_IN seven_CD cattle_NNS (_( A_NP and_CC C_NP )_) and_CC for_IN seven_CD cattle_NNS (_( B_NP and_CC D_NP )_) ._SENT Prospectively_RB designed_VBN and_CC experimentally_RB controlled_VBN sampling_NN and_CC testing_NN of_IN cattle_NNS during_IN a_DT naturally_RB occurring_VBG SFP_NP epizootic_JJ created_VBN fortuitous_JJ circumstances_NNS for_IN analyzing_VBG the_DT kinetics_NN of_IN antibody_NN responses_NNS of_IN cattle_NNS to_TO a_DT native_JJ ,_, wild-type_JJ RBCV_NP infection_NN ._SENT This_DT experiment_NN also_RB provided_VBD an_DT excellent_JJ opportunity_NN to_TO compare_VB antibody_NN reactivities_NNS with_IN both_CC the_DT wild-type_NN RBCV_NP and_CC the_DT highly_JJ cell_NN culture-adapted_JJ and_CC wild-type_JJ EBCV_NP strains_NNS in_IN serum_NN samples_NNS collected_VBN from_IN cattle_NNS involved_VBN in_IN a_DT naturally_RB occurring_VBG RBCV_NP infection_NN ._SENT These_DT conditions_NNS differ_VBP from_IN experimentally_RB induced_VBN infections_NNS that_WDT routinely_RB involve_VBP giving_VBG virus_NN inocula_NNS adapted_VBN to_TO ,_, and_CC propagated_VBD in_IN ,_, cell_NN cultures_NNS ._SENT Importantly_RB ,_, the_DT IN_IN and_CC HAI_NP antibody_NN responses_NNS against_IN RBCV_NP were_VBD significantly_RB greater_JJR than_IN those_DT detected_VBN with_IN the_DT wild-type_JJ EBCV_NP strain_NN LY138-3_NP and_CC the_DT highly_JJ cell_NN culture-adapted_VBN EBCV_NP ._SENT The_DT EBCV_NP strain_NN L9-81_NP is_VBZ virtually_RB identical_JJ to_TO the_DT Norden_NP vaccine_NN strain_NN that_WDT is_VBZ used_VBN in_IN attempts_NNS to_TO protect_VB against_IN intestinal_JJ coronavirus_NN infections_NNS of_IN neonatal_JJ calves_NNS ._SENT Antigens_NNS of_IN the_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP strains_NNS reacted_VBD minimally_RB with_IN antibodies_NNS induced_VBN by_IN naturally_RB occurring_VBG RBCV_NP infections_NNS ._SENT These_DT findings_NNS call_VBP for_IN analysis_NN and_CC a_DT search_NN for_IN appropriate_JJ antigens_NNS in_IN efforts_NNS to_TO immunize_VB cattle_NNS against_IN these_DT currently_RB prevailing_JJ RBCV_NP infections_NNS ._SENT Bovine_JJ coronaviruses_NNS contain_VBP a_DT large_JJ ,_, single-stranded_JJ RNA_NP genome_NN and_CC may_MD mutate_VB in_IN the_DT natural_JJ host_NN to_TO generate_VB quasi-species_NNS differences_NNS ._SENT Phenotypic_JJ changes_NNS may_MD result_VB from_IN adaptation_NN to_TO ,_, and_CC propagation_NN ,_, of_IN the_DT virus_NN in_IN cell_NN cultures_NNS ,_, effecting_VBG the_DT selection_NN of_IN host_NN cell_NN virus_NN mutants_NNS ._SENT Differences_NNS in_IN infectivity_NN between_IN the_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP strain_NN L9-81_NP and_CC the_DT wild-type_NN strains_NNS of_IN RBCV_NP and_CC EBCV_NP consisted_VBD of_IN a_DT greatly_RB expanded_VBN range_NN of_IN permissive_JJ host_NN cells_NNS ._SENT This_DT EBCV_NP strain_NN replicates_VBZ readily_RB ,_, particularly_RB in_IN the_DT presence_NN of_IN trypsin_NN and_CC in_IN cultured_JJ bovine_JJ fetal_JJ kidney_NN ,_, spleen_NN ,_, thyroid_JJ ,_, or_CC adrenal_JJ cells_NNS ,_, as_RB well_RB as_IN in_IN Vero_NP cells_NNS ._SENT In_IN contrast_NN ,_, the_DT wild-type_JJ RBCV_NP strains_NNS had_VBD restricted_VBN host_NN cell_NN ranges_NNS ,_, because_IN only_JJ clone_NN G_NN cells_NNS were_VBD permissive_JJ for_IN initial_JJ isolation_NN from_IN clinical_JJ samples_NNS at_IN low_JJ passage_NN levels_NNS ._SENT Differences_NNS between_IN the_DT RBCV_NP and_CC EBCV_NP strains_NNS also_RB were_VBD observed_VBN in_IN the_DT HA_NP patterns_NNS ,_, cell_NN fusion_NN ,_, and_CC AE_NP activities_NNS ._SENT Antigenic_JJ differences_NNS between_IN RBCV_NP and_CC EBCV_NP could_MD not_RB be_VB detected_VBN by_IN tests_NNS such_JJ as_IN immunodiffusion_NN immunofluorescence_NN ,_, immunoblotting_NN ,_, or_CC enzyme-linked_JJ immunosorbent_JJ assays_NNS with_IN antigens_NNS that_WDT include_VBP all_PDT the_DT structural_JJ proteins_NNS of_IN these_DT coronaviruses_NNS ._SENT MAb_NN specific_NN for_IN S_NP glycoprotein_NN with_IN IN_IN activity_NN distinguished_VBN between_IN EBCV_NP strain_NN L9-81_NP and_CC several_JJ wild-type_NN strains_NNS of_IN EBCV_NP ._SENT Differences_NNS between_IN EBCV_NP strain_NN L9-81_NP and_CC the_DT wild_JJ type_NN strain_NN LY138-3_NP of_IN EBCV_NP in_IN inhibition_NN of_IN AE_NP activity_NN with_IN HE-specific_NP MAb_NP and_CC in_IN HA_NP (_( 4_LS )_) reactivities_NNS were_VBD also_RB detected_VBN ._SENT Genotypic_JJ differences_NNS consisted_VBN of_IN changes_NNS in_IN the_DT regions_NNS of_IN the_DT polymerase_NN and_CC associated_JJ genes_NNS ,_, in_IN the_DT genes_NNS of_IN S_NP and_CC HE_NP glycoproteins_NNS ,_, and_CC in_IN other_JJ nonstructural_JJ genes_NNS ._SENT Nucleotide_NN and_CC deduced_VBN amino_NN acid_NN mutations_NNS were_VBD within_IN the_DT A_NP and_CC B_NP immunoreactive_JJ domains_NNS of_IN the_DT S-I_NP subunit_NN of_IN the_DT spike_NN protein_NN of_IN the_DT RBCV_NP strains_NNS but_CC not_RB the_DT EBCV_NP strains_NNS ,_, which_WDT could_MD be_VB the_DT basis_NN for_IN the_DT observed_JJ diversity_NN in_IN antigenic_JJ stimulation_NN during_IN these_DT naturally_RB occurring_VBG infections_NNS ._SENT Comparatively_RB ,_, the_DT differences_NNS in_IN the_DT kinetics_NN of_IN the_DT primary_JJ bovine_JJ antibody_NN responses_NNS to_TO naturally_RB occurring_VBG and_CC experimentally_RB monitored_VBD RBCV_NP infections_NNS with_IN the_DT antigens_NNS of_IN the_DT wild-type_NN RBCV_NP and_CC EBCV_NP strains_NNS as_RB well_RB as_IN the_DT highly_JJ cell_NN culture-adapted_JJ EBCV_NP appear_VBP to_TO be_VB similar_JJ to_TO responses_NNS of_IN chickens_NNS to_TO infections_NNS with_IN the_DT coronavirus_NN of_IN infectious_JJ bronchitis_NN ._SENT Early_JJ antibodies_NNS generated_VBN during_IN a_DT primary_JJ immune_JJ response_NN distinguished_VBD several_JJ serotypes_NNS of_IN infectious_JJ bronchitis_NN in_IN both_CC IN_IN and_CC HAI_NP tests_NNS ._SENT 